Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological Standardization of Secale Cereale Allergen Extract
NCT01408238Phase 2Completed
- Sponsor
- LETI Pharma
- Start
- Oct 2011
- Primary completion
- Mar 2012
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of secale cereale allergen extract in Rye Pollen Allergy, sponsored by LETI Pharma. Started Oct 2011; status: completed.
02
Drugs
secale cereale allergen extract
03
Conditions
Rye Pollen Allergy
Beyond the preview
Go deeper on NCT01408238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01408238.